Earnings

Checking Out the Fundamental Data for Fairmount Santrol Holdings Inc. (FMSA)

Fairmount Santrol Holdings Inc. (NYSE:FMSA) is an interesting stock at present. Now trading with a market value of 848.27M, the company has a mix of catalysts and obstacles that spring from the nature of its operations. In light of the many issues surrounding this company, we thought it was a good time to take a close look at the numbers in order to form a realistic perspective on the fundamental picture for this stock.

Fairmount Santrol Holdings Inc. (NYSE:FMSA) Fundamentals That Matter

It’s generally a good idea to start with the most fundamental piece of the picture: the balance sheet. The balance sheet health of any company plays a key role in its ability to meet its obligations and maintain the faith of its investment base. For FMSA, the company currently has 178.53 million of cash on the books, which is offset by 12.17 million in current liabilities. The trend over time is important to note. In this case, the company’s debt has been growing. The company also has 1.2 billion in total assets, balanced by 947.83 million in total liabilities, which should give you a sense of the viability of the company under any number of imagined business contexts.

Fairmount Santrol Holdings Inc. (FMSA) saw 21.07 million in free cash flow last quarter, representing a quarterly net change in cash of -32.14 million. Perhaps most importantly where cash movements are concerned, the company saw about 28.28 million in net operating cash flow.



Fairmount Santrol Holdings Inc. (NYSE:FMSA) Revenue Growth Potential

As far as key trends that demonstrate something of the future investment potential of this stock, we need to take a closer look at the top line, first and foremost. Last quarter, the company saw 233.23 million in total revenues. That represents a quarterly year/year change in revenues of 1.04 in sequential terms, the FMSA saw sales decline by 0.35.

But what about the bottom line? After all, that’s what really matters in the end. Fairmount Santrol Holdings Inc. (FMSA) is intriguing when broken down to its core data. The cost of selling goods last quarter was 182.98 million, yielding a gross basic income of 50.24 million. For shareholders, given the total diluted outstanding shares of 228.18 million, this means overall earnings per share of 0.05. Note, this compares with a consensus analyst forecast of 0.13 in earnings per share for its next fiscal quarterly report.




Is Fairmount Santrol Holdings Inc. (NYSE:FMSA) Valuation Attractive

Looking ahead at valuations, according to the consensus, the next fiscal year is forecast to bring about 0.49 in total earnings per share. If we consider a median price to earnings ratio on the stock, that corresponds with a stock price of 6.92. However, one should always remember: the trends are more important than the forecasts. This continues to be an interesting story, and we look forward to updating it again soon on Fairmount Santrol Holdings Inc..

Previous ArticleNext Article

Related Post

Comparing Finisar Corporation (FNSR) and Radian Gr... Finisar Corporation (NASDAQ:FNSR) shares are down more than -13.86% this year and recently increased 2.82% or $0.48 to settle at $17.53. Radian Group ...
Looking at the Big Picture for AcelRx Pharmaceutic... AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX) is on our radar right now but there could still be some opportunities on the horizon. Now trading with a ma...
Bellicum Pharmaceuticals, Inc. (BLCM): Watch Out F... Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) gained 8.29% in yesterday’s session, going up from its prior closing price of $7.96 to $8.62, and has now...
Should You Buy Blue Buffalo Pet Products, Inc. (BU... Blue Buffalo Pet Products, Inc. (NASDAQ:BUFF) shares are up more than 21.77% this year and recently decreased -0.32% or -$0.13 to settle at $39.93. We...
Acadia Healthcare Company, Inc. (ACHC) vs. MEDNAX,... Acadia Healthcare Company, Inc. (NASDAQ:ACHC) shares are down more than -2.57% this year and recently increased 0.50% or $0.16 to settle at $32.25. ME...